211 related articles for article (PubMed ID: 32558590)
1. Current and emerging drug treatment strategies for peripheral arterial disease.
Essa H; Torella F; Lip GYH
Expert Opin Pharmacother; 2020 Sep; 21(13):1603-1616. PubMed ID: 32558590
[TBL] [Abstract][Full Text] [Related]
2. [Peripheral arterial disease: Treatment].
Desormais I; Aboyans V; Pesteil F; Lacroix P
Presse Med; 2018 Jan; 47(1):56-61. PubMed ID: 29273182
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic therapy in peripheral artery disease.
Foley TR; Waldo SW; Armstrong EJ
Vasc Med; 2016 Apr; 21(2):156-69. PubMed ID: 26823456
[TBL] [Abstract][Full Text] [Related]
4. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic therapy for peripheral arterial disease and claudication.
Hiatt WR
J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
[TBL] [Abstract][Full Text] [Related]
6. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
7. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
[TBL] [Abstract][Full Text] [Related]
8. Prescription of Pharmacotherapy and the Incidence of Stroke in Patients With Symptoms of Peripheral Artery Disease.
Nastasi DR; Smith JR; Moxon JV; Trollope A; Golledge J
Stroke; 2018 Dec; 49(12):2953-2960. PubMed ID: 30571405
[TBL] [Abstract][Full Text] [Related]
9. Medical and lifestyle management of peripheral arterial disease.
Parvar SL; Fitridge R; Dawson J; Nicholls SJ
J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic treatment in peripheral artery disease.
Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
[TBL] [Abstract][Full Text] [Related]
11. Do we have a unified consensus on antithrombotic management of PAD?
Poredos P; Antignani PL; Blinc A; Fras Z; Jezovnik MK; Fareed J; Mansilha A
Int Angiol; 2021 Jun; 40(3):229-239. PubMed ID: 33739074
[TBL] [Abstract][Full Text] [Related]
12. Underutilization of medical management of peripheral artery disease among patients with claudication undergoing lower extremity bypass.
Howard R; Albright J; Powell C; Osborne N; Corriere M; Laveroni E; Sukul D; Goodney P; Henke P
J Vasc Surg; 2022 Oct; 76(4):1037-1044.e2. PubMed ID: 35709853
[TBL] [Abstract][Full Text] [Related]
13. How To Assess a Claudication and When To Intervene.
Hossain P; Kokkinidis DG; Armstrong EJ
Curr Cardiol Rep; 2019 Nov; 21(12):138. PubMed ID: 31728766
[TBL] [Abstract][Full Text] [Related]
14. Peripheral arterial disease: a review of disease awareness and management.
Watson K; Watson BD; Pater KS
Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic strategies for patients with coronary and lower extremity peripheral artery diseases: a narrative review.
De Luca L; Bonaca MP; Magnani G
Expert Rev Cardiovasc Ther; 2020 Dec; 18(12):881-889. PubMed ID: 33021875
[TBL] [Abstract][Full Text] [Related]
16. The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication (Evol-PAD study).
Clavijo LC; Caro J; Choi J; Caro JA; Tun H; Rowe V; Kumar SR; Shavelle DM; Matthews RV
Cardiovasc Revasc Med; 2023 Oct; 55():1-5. PubMed ID: 37142533
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of clopidogrel treatment and platelet responsiveness in peripheral arterial procedures.
Spiliopoulos S; Pastromas G; Diamantopoulos A; Katsanos K
Expert Opin Pharmacother; 2014 Oct; 15(15):2205-17. PubMed ID: 25162471
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotics in stable peripheral artery disease.
Kaplovitch E; Rannelli L; Anand SS
Vasc Med; 2019 Apr; 24(2):132-140. PubMed ID: 30799766
[TBL] [Abstract][Full Text] [Related]
19. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
[TBL] [Abstract][Full Text] [Related]
20. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
Hiatt WR; Fowkes FG; Heizer G; Berger JS; Baumgartner I; Held P; Katona BG; Mahaffey KW; Norgren L; Jones WS; Blomster J; Millegård M; Reist C; Patel MR;
N Engl J Med; 2017 Jan; 376(1):32-40. PubMed ID: 27959717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
